In autoimmunity, CD166 has been implicated in the pathogenesis of lupus nephritis, rheumatoid arthritis, Sjogren’s syndrome, and inflammatory bowel disease in which both CD6 and CD166 are overexpressed (28, 31, 32, 48). Here, ALCAM is linked to lupus nephritis.